Tadocizumab
Tadocizumab
Tadocizumab (pronounced ta-doh-siz-uh-mab) is a monoclonal antibody designed for the treatment of various diseases.
Etymology
The name "Tadocizumab" is derived from the standard nomenclature for monoclonal antibodies. The suffix "-mab" indicates that it is a monoclonal antibody, while the prefix "Tado-" does not have a specific meaning and is often chosen arbitrarily.
Function
Tadocizumab works by binding to specific proteins on the surface of cells, blocking the action of these proteins and preventing them from causing damage to the body. This can help to reduce the symptoms of the disease and slow its progression.
Related Terms
- Monoclonal antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
- Protein: A molecule composed of amino acids that performs a vast array of functions within organisms.
- Disease: A particular abnormal condition that negatively affects the structure or function of all or part of an organism.
Usage
Tadocizumab is used in the treatment of various diseases. The specific diseases that it is used to treat can vary depending on the specific proteins that it is designed to target.
Side Effects
Like all medications, Tadocizumab can cause side effects. These can include allergic reactions, fever, and nausea. If you experience any side effects while taking Tadocizumab, you should contact your doctor immediately.
External links
- Medical encyclopedia article on Tadocizumab
- Wikipedia's article - Tadocizumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski